NL-OMON47925
Recruiting
Not Applicable
Identification of biomarkers of hypertrophic cardiomyopathy development and progression in Dutch MYBPC3 founder mutation carriers - BIO FOr CARe
niversitair Medisch Centrum Utrecht0 sites1,000 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 1,000
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational invasive
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •MYBPC3 founder mutation carrier and 18 years or older
Exclusion Criteria
- •Cardiac transplant
Investigators
Similar Trials
Unknown
Not Applicable
Emerging Biomarkers in HypertensionHypertensionNCT02064218University of Pavia
Unknown
Not Applicable
New Diagnostic Strategy in Hypertrophic CardiomyopathyHypertrophic CardiomyopathyNCT02520856Assistance Publique Hopitaux De Marseille200
Active, not recruiting
Not Applicable
HCMR - Novel Markers of Prognosis in Hypertrophic CardiomyopathyHypertrophic CardiomyopathyNCT01915615University of Virginia2,750
Recruiting
Not Applicable
Hemodynamic characterization in hypertrophic cardiomyopathy after septal myectomy +/- mitral valve repair: a 4D-flow MRI studyHypertrophic cardiomyopathy10028593NL-OMON50330Amsterdam UMC20
Recruiting
Not Applicable
Identification of new biomarkers in cardiac ischemiaI25I25.1Chronic ischaemic heart diseaseAtherosclerotic heart diseaseDRKS00030534Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg200